⌘K

Login Start Free

Home/Filings/4/0001127602-16-036018

4//SEC Filing

ARIAD PHARMACEUTICALS INC 4

Accession 0001127602-16-036018

CIK 0000884731operating

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:41 PM ET

Size

26.5 KB

Accession

0001127602-16-036018

Insider Transaction Report

Form 4

Period: 2015-12-31

ARIAD PHARMACEUTICALS INCARIA

BERGER HARVEY J M D

DirectorChairman & CEO

Transactions

Tax Payment
Common Stock
2015-12-31$6.25/sh−82,128$513,300→ 1,732,111 total
Tax Payment
Common Stock
2015-12-31$6.25/sh−22,420$140,125→ 1,640,239 total
Exercise/Conversion
Restricted Stock Units
2015-12-31−36,000→ 0 total
→ Common Stock (36,000 underlying)
Exercise/Conversion
Restricted Stock Units
2015-12-31−174,000→ 0 total
→ Common Stock (174,000 underlying)
Exercise/Conversion
Restricted Stock Units
2015-12-31−345,000→ 0 total
→ Common Stock (345,000 underlying)
Exercise/Conversion
Performance stock unit
2015-12-31−47,500→ 0 total
→ Common Stock (47,500 underlying)
Tax Payment
Common Stock
2015-12-31$6.25/sh−16,992$106,200→ 1,433,000 total
Exercise/Conversion
Common Stock
2015-12-31+345,000→ 1,778,000 total
Tax Payment
Common Stock
2015-12-31$6.25/sh−162,841$1,017,756→ 1,615,159 total
Exercise/Conversion
Common Stock
2015-12-31+36,000→ 1,449,992 total
Exercise/Conversion
Common Stock
2015-12-31+174,000→ 1,814,239 total
Exercise/Conversion
Common Stock
2015-12-31+47,500→ 1,662,659 total

Holdings

Common Stock
(indirect: Daughter)
246,054
Common Stock
(indirect: Daughter)
248,745
Common Stock
(indirect: By LLC)
1,864,286
Common Stock
(indirect: By Spouse)
245,251

Footnotes (9)

[F1]Shares were acquired upon vesting of restricted stock units awarded on March 19, 2013.
[F2]Represents shares withheld to satisfy witholding tax requirements.
[F3]Shares were acquired upon vesting of restricted stock units awarded on April 28, 2015.
[F4]Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
[F5]Shares were acquired upon vesting of restricted stock units awarded on March 20, 2012.
[F6]The reporting person is a managing member of this LLC.
[F7]Each restricted stock unit represents a right to receive one share of ARIAD common stock.
[F8]The restricted and performance stock units vested on December 31, 2015.
[F9]Each performance stock unit represents a right to receive one share of ARIAD common stock.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

ARIAD PHARMACEUTICALS INC

CIK 0000884731

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000884731

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 5:41 PM ET
Size: 26.5 KB

View on SEC.gov